Cita APA

Ayala, R., Carreño-Tarragona, G., Barragán, E., Boluda, B., Larráyoz, M. J., Chillón, M. C., . . . Montesinos, P. (2022). Impact of FLT3–ITD mutation status and its ratio in a cohort of 2901 patients undergoing upfront intensive chemotherapy: A PETHEMA registry study.

Citación estilo Chicago

Ayala, Rosa, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María J. Larráyoz, María Carmen Chillón, José Antonio Pérez Simón, y Pau Montesinos. Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. 2022.

Cita MLA

Ayala, Rosa, et al. Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. 2022.